Extended-spectrum β-lactamase-producing Enterobacteriaceae in Bulgarian hospitals

Microbial Drug Resistance

Volumn 14, Issue 2, 2008, Pages 119-128

  Markovska, Rumyana ^a   Schneider, Ines ^b   Keuleyan, Emma ^c   Sredkova, Mariya ^d   Ivanova, Dobrinka ^e   Markova, Boyka ^e   Lazarova, Grozdanka ^f   Dragijeva, Elisaveta ^e   Savov, Encho ^g   Haydouchka, Irina ^h   Hadjieva, Nasya ^e   Setchanova, Lena ^a   Mitov, Ivan ^a   Bauernfeind, Adolf ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b MICOER Institute   (Germany)

^c MINISTRY OF THE INTERIOR   (Bulgaria)

^d MEDICAL UNIVERSITY PLEVEN   (Bulgaria)

^e UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^f University Hospital Stara Zagora   (Bulgaria)

^g MILITARY MEDICAL ACADEMY   (Bulgaria)

^h UNIVERSITY HOSPITAL ST GEORGE   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE CTX M; BETA LACTAMASE SHV; EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAM; BETA LACTAMASE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BULGARIA; DNA FINGERPRINTING; ENTEROBACTERIACEAE; HOSPITAL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PREVALENCE; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; BIOSYNTHESIS; CLASSIFICATION; DRUG EFFECT; ENTEROBACTER INFECTION; ENZYMOLOGY; GENETICS; HUMAN; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; STATISTICS;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; BULGARIA; DNA FINGERPRINTING; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE;

EID: 50149122292     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2008.0814     Document Type: Article

References (39)

1. Archambault, M., P. Petrov, R.S. Hendriksen, G. Asseva, A. Bangtrakulnonth, H. Hasman, and F.M. Aarestrup. 2006. Molecular characterization and occurrence of extended-spectrum beta-lactamase resistance genes among Salmonella enterica serovar Corvallis from Thailand, Bulgaria, and Denmark. Microb. Drug Resist. 12:192-198.
2. Bauernfeind, A., I. Schneider, R. Jungwirth, H. Sahly, and U. Ullmann. 1999. A novel type of AmpC β-lactamase, ACC-1, produced by a Klebsiella pneumoniae causing nosocomial pneumonia. Antimicrob. Agents Chemother. 43: 1924-1931.
3. Bedenic, B., H. Schmidt, S. Herold, M. Monaco, V. Plecko, S. Kalenic, S. Katic, and J. Skrlin-Subic. 2005. Epidemic and endemic spread of Klebsiella pneumoniae producing SHV-5 b-lactamase in Dubrava University Hospital, Zagreb, Croatia. J. Chemother. 17:367-375.
4. Bojorquez, D., M. Belei, S.F. Delira, S. Sholly, J. Mead, and M.E. Tolmasky. 1998. Characterization of OXA-9, a betalactamase encoded by the multiresistance transposon Tn1331. Cell. Mol. Biol. (Noisy-le-grand) 44:483-491.
5. Bonnet, R. 2004. Growing group of extended-spectrum betalactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14.
6. Boyd, D.A., S. Tyler, S. Christianson, A. McGeer, M.P. Muller, B.M. Willey, E. Bryce, M. Gardam, P. Nordmann, and M.R. Mulvey. 2004. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extendedspectrum beta-lactamase involved in an outbreak in longterm-care facilities in Toronto, Canada. Antimicrob. Agents Chemother. 48:3758-3764.
7. Bradford, P.A. 2001. Extended-spectrum β-lactamases in the 21st Century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.
8. Canton, R., and T.M. Coque. 2006. The CTX-M betalactamase pandemic. Curr. Opin. Microbiol. 9:466-475.
9. Damjanova, I., A. Toth, J. Paszti, M. Jakab, H. Milch, A. Bauernfeind, and M. Fuzi. 2007. Epidemiology of SHV-type β-lactamase-producing Klebsiella spp. from outbreaks in five geographically distant Hungarian neonatal intensive care units: widespread dissemination of epidemic R-plasmids. Int. J. Antimicrob. Agents 29:665-671.
10. Filip, R., L. Chihu-Amparan, G. Coman, M.E. Velazquez, and J. Silva. 2004. Molecular characterization of b-lactam resistance of Salmonella isolates from pediatric patients in Romania. J. Chemother. 16:337-342.
11. Hanson, N.D., K.S. Thomson, E.S. Moland, C.C. Sanders, G. Berthold, and R.G. Penn. 1999. Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs and a plasmid-mediated AmpC. J. Antimicrob. Chemother. 44:377-380.
12. Hernandez, J.R., L. Martinez-Martinez, R. Canton, T.M. Coque, and A. Pascual; Spanish Group for Nosocomial Infections (GEIH). 2005. Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain. Antimicrob. Agents Chemother. 49:2122-2125.
13. Jacoby, G., and R. Vacheva-Dobrevsky. 2003. Epidemiology of extended spectrum β-lactamases in Sofia, Bulgaria. Eur. J. Clin. Microbiol. Infect. Dis. 22:385-388.
14. Jarlier, V., M. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
15. Jeong, S.H., I.K. Bae, J.H. Lee, S.G. Sohn, G.H. Kang, G.J. Jeon, Y.H. Kim, B.C. Jeong, and S.H. Lee. 2004. Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean nationwide survey. J. Clin. Microbiol. 42:2902-2906.
16. Jutersek, B., A. Baraniak, T. Zohar-Cretnik, A. Storman, E. Sadowy, and M. Gniadkowski. 2003. Complex endemic situation regarding extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a hospital in Slovenia. Microb. Drug Resist. 9 (Suppl):25-33.
17. Karim, A., L. Poirel, S. Nagarajan, and P. Nordmann. 2001. Plasmid-mediated extended-spectrum β-lactamases (CTXM-3 like) from India and association with insertion sequence ISEcp1. FEMS Microbiol. Lett. 201:237-241.
18. Keuleyan, E., V. Kaludova, and R. Marinova. 1992. Comparative susceptibility to beta-lactams and spectra of beta-lactamases in clinical Enterobacteriaceae strains. In: Program and Abstracts of the 4th Biennial Conference on Chemotherapy of Infectious Diseases and Malignancies (BICON). Prague, Czechoslovakia: FESCI (abstract 217).
19. Keuleyan, E., and APUA-Bulgaria ARS Study group. 2002. Short term resistance surveillance may also be helpful. In: Program and Abstracts of the 10th Congress of the Bulgarian Microbiologists with International Participation. Plovdiv, Bulgaria: Union of Scientists in Bulgaria-Bulgarian Society for Microbiology (abstract 31).
20. Lartigue, M., L. Poirel, C. Heritier, V. Tolun, and P. Nordmann. 2003. First description of CTX-M-15 producing Klebsiella pneumoniae in Turkey. J. Antimicrob. Chemother. 53:315-316.
21. Lee, S., Y.J. Park, M. Kim, H.K. Lee, K. Han, C.S. Kang, and M.W. Kang. 2005. Prevalence of Ambler class A and D β-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J. Antimicrob. Chemother. 56:122-127.
22. Machado, E., T.M. Coque, R. Canton, F. Baquero, J.C. Sousa, and L. Peixe; Portuguese Resistance Study Group. 2006. Dissemination in Portugal of CTX-M-15, OXA-1-, and TEM-1-producing Enterobacteriaceae strains containing the aac(6')-Ib-cr gene, which encodes an aminoglycoside- and fluoroquinolone- modifying enzyme. Antimicrob. Agents Chemother. 50:3220-3221.
23. Markovska, R., I. Schneider, E. Keuleyan, and A. Bauernfeind. 2004. Extended spectrum β-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria. Clin. Microbiol. Infect. 10:752-755.
24. Markovska, R., K. Rachkova, I. Schneider, E. Keuleyan, and A. Bauernfeind. 2005. Multiresistant SHV-2-producing Salmonella enterica serotype Corvallis in Bulgaria. J. Chemother. 17:568-569.
25. CTX-M-3 in Bulgaria. Eur. J. Clin. Microbiol. Infect. Dis. 25:123-125.
26. Matthew, M., A.M. Harris, M.J. Marshall, and G.W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J. Gen. Microbiol. 88:169-178.
27. Mulvey, M.R., E. Bryce, D. Boyd, M. Ofner-Agostini, S. Christianson, A.E. Simor, and S. Paton; Canadian Hospital Epidemiology Committee, Canadian Nosocomial Infection Surveillance Program, Health Canada. 2004. Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob. Agents Chemother. 48:1204-1214.
28. Naumiuk, L., A. Baraniak, M. Gniadkowski, B. Krawczyk, B. Rybak, E. Sadowy, A. Samet, and J. Kur. 2004. Molecular epidemiology of Serratia marcescens in two hospitals in Gdansk, Poland, over a 5-year period. J. Clin. Microbiol. 42:3108-3116.
29. NCCLS (ed.). 2002. M100-S12 performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. Wayne, PA.
30. Neonakis, I.K., E.V. Scoulica, S.K. Dimitriou, A.I. Gikas, and Y.J. Tselentis. 2003. Molecular epidemiology of extended-spectrum β-lactamases produced by clinical isolates in a university hospital in Greece: detection of SHV-5 in Pseudomonas aeruginosa and prevalence of SHV-12. Microb. Drug Resist. 9:161-165.
31. Paterson, D.L., K.M. Hujer, A.M. Hujer, B. Yeiser, M.D. Bonomo, L.B. Rice, and R.A. Bonomo; International Klebsiella Study Group. 2003. Extended-spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-Type b-lactamases. Antimicrob. Agents Chemother. 47:3554-3560.
32. Petrov, M., N. Hadjieva, T. Kantardjiev, T. Velinov, and A. Bachvarova. 2005. Surveillance of antimicrobial resistance in Bulgaria - a synopsis from BulSTAR 2003. Euro. Surveill. 10:79-82.
33. Pitout, J.D., D.L. Church, D.B. Gregson, B.L. Chow, M. McCracken, M.R. Mulvey, and K.B. Laupland. 2007. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob. Agents Chemother. 51: 1281-1286.
34. Ploy, M.C., P. Courvalin, and T. Lambert. 1998. Characterization of In40 of Enterobacter aerogenes BM2688, a class 1 integron with two new gene cassettes, cmlA2 and qacF. Antimicrob. Agents Chemother. 42:2557-2563.
35. Schneider, I., R. Markovska, E. Keuleyan, M. Sredkova, K. Rachkova, I. Mitov, and A. Bauernfeind. 2007. Dissemination and persistence of a plasmid-mediated TEM-3-like β-lactamase, TEM-139, among Enterobacteriaceae in Bulgaria. Int. J. Antimicrob. Agents 29:710-714.
36. Tasli, H., and I.H. Bahar. 2005. Molecular characterization of TEM- and SHV-derived extended-spectrum β-lactamases in hospital-based Enterobacteriaceae in Turkey. Jpn. J. Infect. Dis. 58:162-167.
37. Touati, A., S. Benallaoua, D. Forte, J. Madoux, L. Brasme, and C. de Champs. 2006. First report of CTX-M-15 and CTXM-3 beta-lactamases among clinical isolates of Enterobacteriaceae in Bejaia, Algeria. Int. J. Antimicrob. Agents 27:397-402.
38. Versalovic, J., T. Koeuth, and J. Lupski. 1991. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic. Acids Res. 19:6823-6831.
39. Zarnayová, M., E. Siebor, A. Péchinot, J.M. Duez, H. Bujdáková, R. Labia, and C. Neuwirth. 2005. Survey of Enterobacteriaceae producing extended-spectrum β-lactamases in a Slovak hospital: dominance of SHV-2a and characterization of TEM-132. Antimicrob. Agents Chemother. 49: 3066-3069.